Position in ANAB
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$3,138,811
+$396,589 QoQ
Shares Held
84,894
+0.1% QoQ
Ownership
0.292%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 39%
Shared 0%
None 61%
Common Shares in ANAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Fisher Asset Management, LLC holds $807,507,065 across 59 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
957,691 | $78,061,393 | |
| 2 | RCUS |
Arcus Biosciences, Inc.
|
2,139,396 | $65,957,578 | |
| 3 | CYTK |
Cytokinetics Inc
|
743,697 | $63,355,547 | |
| 4 | DNLI |
Denali Therapeutics Inc.
|
2,414,162 | $62,092,246 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
207,693 | $38,896,745 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
|
121,440 | $38,385,969 | |
| 7 | CLDX |
Celldex Therapeutics, Inc.
|
985,677 | $36,677,041 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
427,713 | $33,477,096 |
All Filings in ANAB
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,138,811 | 56,596 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $2,742,222 | 56,564 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $1,802,841 | 58,878 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $1,307,557 | 58,899 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,094,539 | 58,878 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $779,547 | 58,878 | Shares | Defined | 2025-02-05 | |
| 2024-09-30 | $2,075,254 | 61,948 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,628,702 | 64,992 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,591,124 | 70,654 | Shares | Defined | 2024-05-09 | |
| 2023-12-31 | $1,524,118 | 71,154 | Shares | Defined | 2024-03-05 | |
| 2023-09-30 | $1,268,942 | 70,654 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,437,102 | 70,654 | Shares | Sole | 2023-12-12 | |
| 2023-03-31 | $1,537,434 | 70,654 | Shares | Sole | 2023-12-12 | |
| 2022-12-31 | $2,403,274 | 77,550 | Shares | Defined | 2023-02-03 | |
| 2022-09-30 | $1,978,304 | 77,550 | Shares | Defined | 2022-11-08 | |
| 2022-06-30 | $1,574,058 | 77,540 | Shares | Defined | 2022-08-09 | |
| 2022-03-31 | $1,679,570 | 67,889 | Shares | Defined | 2022-05-05 | |
| 2021-12-31 | $2,064,882 | 59,421 | Shares | Defined | 2022-02-02 | |
| 2021-09-30 | $1,248,035 | 46,019 | Shares | Defined | 2021-10-26 | |
| No filing history on record for this holder in this stock. | ||||||